Literature DB >> 1585910

Cephalosporin-induced hemolysis: a case report and review of the literature.

W C Ehmann1.   

Abstract

Cephalosporins are commonly used drugs that interact with red blood cell membranes. They frequently cause a positive direct antiglobulin test but rarely cause hemolysis. A case of cefotetan-induced hemolytic anemia is described in which two types of antibodies were detected. One reacted with red blood cells by a hapten mechanism, the other reacted with drug to form immune complexes. This case is compared with the 13 cases of cephalosporin-induced hemolytic anemia reported to date. Understanding the interactions of red blood cells and cephalosporins is critical to the safe use of these commonly prescribed drugs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1585910     DOI: 10.1002/ajh.2830400209

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

1.  Use of gel microcolumn assay for the detection of drug-induced positive direct antiglobulin tests.

Authors:  M C Z Novaretti; C R Sopeleti; P E Dorlhiac-Llacer; D A F Chamone
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

2.  Hematologic effects of linezolid: summary of clinical experience.

Authors:  Stanton L Gerson; Sheldon L Kaplan; Jon B Bruss; Vu Le; Felix M Arellano; Barry Hafkin; David J Kuter
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

3.  Worldwide assessment of linezolid's clinical safety and tolerability: comparator-controlled phase III studies.

Authors:  Ethan Rubinstein; Raul Isturiz; Harold C Standiford; Leon G Smith; Thomas H Oliphant; Sue Cammarata; Barry Hafkin; Vu Le; Jack Remington
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

4.  Anti-Thrombotic, Anti-Oxidant and Haemolysis Activities of Six Edible Insect Species.

Authors:  Su-Jin Pyo; Deok-Gyeong Kang; Chuleui Jung; Ho-Yong Sohn
Journal:  Foods       Date:  2020-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.